Neurodegenerative Diseases: Magnetic resonance spectroscopy of neurodegenerative illness

[1]  Mauricio Castillo,et al.  MR spectroscopy of brain tumors. , 2003, Magnetic resonance imaging clinics of North America.

[2]  F. Shic,et al.  Reduced glutamate neurotransmission in patients with Alzheimer's disease–an in vivo 13C magnetic resonance spectroscopy study , 2003, Magnetic Resonance Materials in Physics, Biology and Medicine.

[3]  D. Rothman,et al.  Neuronal and glial metabolite content of the epileptogenic human hippocampus , 2002, Annals of neurology.

[4]  M. Baslow,et al.  Evidence supporting a role for N-acetyl-l-aspartate as a molecular water pump in myelinated neurons in the central nervous system An analytical review , 2002, Neurochemistry International.

[5]  K. Petersen,et al.  Astroglial Contribution to Brain Energy Metabolism in Humans Revealed by 13C Nuclear Magnetic Resonance Spectroscopy: Elucidation of the Dominant Pathway for Neurotransmitter Glutamate Repletion and Measurement of Astrocytic Oxidative Metabolism , 2002, The Journal of Neuroscience.

[6]  S. Bluml,et al.  Tricarboxylic acid cycle of glia in the in vivo human brain , 2002, NMR in biomedicine.

[7]  R. Kuzniecky,et al.  Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss? , 2001, Archives of neurology.

[8]  K Ugurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at 7 T , 2001, Magnetic resonance in medicine.

[9]  O. Andreassen,et al.  Creatine Increases Survival and Delays Motor Symptoms in a Transgenic Animal Model of Huntington's Disease , 2001, Neurobiology of Disease.

[10]  O. Andreassen,et al.  Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation , 2001, Journal of neurochemistry.

[11]  J. Miller,et al.  Transient Focal Cerebral Ischemia , 2001 .

[12]  B. Ross,et al.  1‐13C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders , 2001, NMR in biomedicine.

[13]  J. Gotman,et al.  Time Course of Postoperative Recovery of N‐Acetyl‐Aspartate in Temporal Lobe Epilepsy , 2001, Epilepsia.

[14]  R. Kopito,et al.  Aggresomes, inclusion bodies and protein aggregation. , 2000, Trends in cell biology.

[15]  D. Manners,et al.  Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy , 2000, Annals of neurology.

[16]  Ole A. Andreassen,et al.  Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease , 2000, The Journal of Neuroscience.

[17]  O. Andreassen,et al.  Nonlinear Decrease over Time in N‐Acetyl Aspartate Levels in the Absence of Neuronal Loss and Increases in Glutamine and Glucose in Transgenic Huntington's Disease Mice , 2000, Journal of neurochemistry.

[18]  B. Jenkins,et al.  Magnetic resonance spectroscopy in toxic encephalopathy and neurodegeneration. , 1999, Current opinion in neurology.

[19]  R Gruetter,et al.  Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. , 1999, Journal of magnetic resonance.

[20]  F. Podo.  Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[21]  Chen Chang,et al.  Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy , 1999, Neuroscience.

[22]  K R Thulborn,et al.  Comprehensive MR imaging protocol for stroke management: tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies. , 1999, Radiology.

[23]  J. Dichgans,et al.  Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration? , 1999, Current opinion in neurology.

[24]  A. Heerschap,et al.  Proton MR spectroscopy in a child with pyruvate dehydrogenase complex deficiency. , 1999, Magnetic resonance imaging.

[25]  T. Ng,et al.  1H-MRS evidence of neurodegeneration and excess glutamate glutamine in ALS medulla , 1999, Neurology.

[26]  D. Arnold,et al.  Biological markers in the diagnosis and treatment of ALS , 1999, Journal of the Neurological Sciences.

[27]  D J Drost,et al.  Factors affecting the quantification of short echo in‐vivo 1H MR spectra: prior knowledge, peak elimination, and filtering , 1999, NMR in biomedicine.

[28]  D. Dubowitz,et al.  In vivo magnetic resonance spectroscopy of human fetal neural transplants , 1999, NMR in biomedicine.

[29]  M W Weiner,et al.  Reduced MTR in the corticospinal tract and normal T2 in amyotrophic lateral sclerosis. , 1998, Magnetic resonance imaging.

[30]  Bruce G. Jenkins,et al.  Combined PET/MRS brain studies show dynamic and long-term physiological changes in a primate model of Parkinson disease , 1998, Nature Medicine.

[31]  B. Barbiroli,et al.  Aspects of human bioenergetics as studied in vivo by magnetic resonance spectroscopy. , 1998, Biochimie.

[32]  N. Bansal,et al.  Three‐dimensional triple‐quantum‐filtered 23Na imaging of the dog head in vivo , 1998, Journal of magnetic resonance imaging : JMRI.

[33]  H. K. Lee,et al.  Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy. , 1998, Investigative radiology.

[34]  P. Kingsley,et al.  Magnetic resonance spectroscopy: use in monitoring MELAS treatment. , 1998, Archives of neurology.

[35]  D. Arnold,et al.  Recovery of N‐acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy , 1998, Neuroreport.

[36]  B R Rosen,et al.  1H NMR spectroscopy studies of Huntington's disease , 1998, Neurology.

[37]  B D Ross,et al.  Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases , 1998, Neurology.

[38]  M. Moskowitz,et al.  Attenuation of Delayed Neuronal Death after Mild Focal Ischemia in Mice by Inhibition of the Caspase Family , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  Z. Argov.  Functional Evaluation Techniques in Mitochondrial Disorders , 1998, European Neurology.

[40]  J. B. Hutchins,et al.  Mitochondrial Manganese Superoxide Dismutase Prevents Neural Apoptosis and Reduces Ischemic Brain Injury: Suppression of Peroxynitrite Production, Lipid Peroxidation, and Mitochondrial Dysfunction , 1998, The Journal of Neuroscience.

[41]  Bruce R. Rosen,et al.  Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease , 1998, The Journal of Neuroscience.

[42]  P M Matthews,et al.  Axonal dysfunction and disability in a relapse of multiple sclerosis: Longitudinal study of a patient , 1997, Neurology.

[43]  J. Pettegrew,et al.  Magnetic Resonance Spectroscopic Changes in Alzheimer's Disease a , 1997, Annals of the New York Academy of Sciences.

[44]  A. Simmons,et al.  Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: A proton magnetic resonance spectroscopy study , 1997, Neurology.

[45]  B Barbiroli,et al.  Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. , 1997, Cellular and molecular biology.

[46]  R G Shulman,et al.  In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  B. Rosen,et al.  Energy metabolism defects in Huntington's disease and effects of coenzyme Q10 , 1997, Annals of neurology.

[48]  Jullie W Pan,et al.  Quantitative 1H spectroscopic imaging of human brain at 4.1 T using image segmentation , 1996, Magnetic resonance in medicine.

[49]  B R Rosen,et al.  Non-Invasive Neurochemical Analysis of Focal Excitotoxic Lesions in Models of Neurodegenerative Illness Using Spectroscopic Imaging , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  K. Behar,et al.  Short echo time proton magnetic resonance spectroscopic imaging of macromolecule and metabolite signal intensities in the human brain , 1996, Magnetic resonance in medicine.

[51]  J. Rothstein,et al.  Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex , 1996, Annals of neurology.

[52]  J. Pettegrew,et al.  Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain , 1996, Neurobiology of Aging.

[53]  H. B. Verheul,et al.  Status of the Neonatal Rat Brain after NMDA‐Induced Excitotoxic Injury as Measured by MRI, MRS and Metabolic Imaging , 1996, NMR in biomedicine.

[54]  B. Rosen,et al.  NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals , 1996, Brain Research.

[55]  J. Schulz,et al.  Improved Therapeutic Window for Treatment of Histotoxic Hypoxia with a Free Radical Spin Trap , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[56]  P. Allen,et al.  Generalized mitochondrial dysfunction in Parkinson's disease detected by magnetic resonance spectroscopy of muscle , 1995, Neurology.

[57]  T. Kachi,et al.  Magnetic resonance imaging of the corticospinal tracts in amyotrophic lateral sclerosis , 1995, Journal of the Neurological Sciences.

[58]  P. Matthews,et al.  Reversible decreases in N‐acetylaspartate after acute brain injury , 1995, Magnetic resonance in medicine.

[59]  A. Levey,et al.  Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis , 1995, Annals of neurology.

[60]  L Symon,et al.  Investigation into the Role of N‐Acetylaspartate in Cerebral Osmoregulation , 1995, Journal of neurochemistry.

[61]  P. M. Matthews,et al.  Short‐term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders , 1995, Neurology.

[62]  F. Fonnum,et al.  Glial‐Neuronal Interactions as Studied by Cerebral Metabolism of [2‐13C]Acetate and [1‐13C]Glucose: An Ex Vivo 13C NMR Spectroscopic Study , 1995, Journal of neurochemistry.

[63]  H. Möller,et al.  Localized proton NMR spectroscopy in the striatum of patients with idiopathic parkinson's disease: a multicenter pilot study , 1995 .

[64]  T. Richards,et al.  Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. , 1995, The American journal of psychiatry.

[65]  B. Rosen,et al.  Involvement of Free Radicals in Excitotoxicity In Vivo , 1995, Journal of neurochemistry.

[66]  B D Ross,et al.  Probable Alzheimer disease: diagnosis with proton MR spectroscopy. , 1995, Radiology.

[67]  R. Gruetter,et al.  Simultaneous Determination of the Rates of the TCA Cycle, Glucose Utilization, α-Ketoglutarate/Glutamate Exchange, and Glutamine Synthesis in Human Brain by NMR , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[68]  B. Rosen,et al.  Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate , 1994, Annals of neurology.

[69]  Rolf Gruetter,et al.  Localized 13C NMR Spectroscopy in the Human Brain of Amino Acid Labeling from d‐[1‐13C]Glucose , 1994, Journal of neurochemistry.

[70]  Jullie W Pan,et al.  Detection of brain glutamate and glutamine in spectroscopic images at 4.1 T , 1994, Magnetic resonance in medicine.

[71]  B. Rosen,et al.  Malonate produces striatal lesions by indirect NMDA receptor activation , 1994, Brain Research.

[72]  G J Barker,et al.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. , 1994, Brain : a journal of neurology.

[73]  K. Hossmann.  Glutamate‐Mediated Injury in Focal Cerebral Ischemia: The Excitotoxin Hypothesis Revised , 1994, Brain pathology.

[74]  B. Rosen,et al.  Evidence for irnnairment of energy metabofism in vivo in Huntington's disease using localized 1H NMR spectroscopy , 1993, Neurology.

[75]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[76]  B. Hyman,et al.  Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[77]  P. Zaniol,et al.  Defective Brain Energy Metabolism Shown by in vivo 31P MR Spectroscopy in 28 Patients with Mitochondrial Cytopathies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[78]  P. Matthews,et al.  Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease , 1993, Neurology.

[79]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[80]  G. Radda.  Control, bioenergetics, and adaptation in health and disease: noninvasive biochemistry from nuclear magnetic resonance , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  B. Siesjö.  Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. , 1992, Journal of neurosurgery.

[82]  M. Nielsen,et al.  Facilitating Postischemic Reduction of Cerebral Lactate in Rats , 1992, Stroke.

[83]  A. Blamire,et al.  Spectroscopic imaging of stroke in humans , 1992, Neurology.

[84]  M Noble,et al.  Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro , 1992, Journal of neurochemistry.

[85]  G Serratrice,et al.  31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies , 1992, Neurology.

[86]  A. Lajtha,et al.  Decreased brain N-acetylaspartate in Huntington's disease , 1992, Brain Research.

[87]  R G Shulman,et al.  NMR Determination of Intracerebral Glucose Concentration and Transport Kinetics in Rat Brain , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[88]  B. Rosen,et al.  1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism , 1992, Journal of neurochemistry.

[89]  J. Coyle,et al.  Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.

[90]  R. Shulman,et al.  Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[91]  W. Bank,et al.  Phosphorus magnetic resonance spectroscopy (31P MRS) in neuromuscular disorders , 1991, Annals of neurology.

[92]  J. Alger,et al.  A pitfall associated with lactate detection using stimulated‐echo proton spectroscopy , 1991, Magnetic resonance in medicine.

[93]  P. Narayana,et al.  Serial proton magnetic resonance spectroscopy of ischemic brain injury in humans. , 1990, Investigative radiology.

[94]  H. Bachelard,et al.  Cerebral metabolism of acetate and glucose studied by 13C-n.m.r. spectroscopy. A technique for investigating metabolic compartmentation in the brain. , 1990, The Biochemical journal.

[95]  W. Sherman,et al.  myo-Inositol: A Newly Identified Nonnitrogenous Osmoregulatory Molecule in Mammalian Brain , 1989, Pediatric Research.

[96]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[97]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[98]  A. Schurr,et al.  Lactate-supported synaptic function in the rat hippocampal slice preparation. , 1988, Science.

[99]  P. Bottomley.  Spatial Localization in NMR Spectroscopy in Vivo , 1987, Annals of the New York Academy of Sciences.

[100]  Jens Frahm,et al.  Localized proton spectroscopy using stimulated echoes. , 1987 .

[101]  S K Hilal,et al.  In vivo NMR imaging of tissue sodium in the intact cat before and after acute cerebral stroke. , 1983, AJNR. American journal of neuroradiology.

[102]  Morris H. Baslow,et al.  Brain N-acetylaspartate as a molecular water pump and its role in the etiology of canavan disease , 2007, Journal of Molecular Neuroscience.

[103]  M. Norenberg,et al.  Effect of Ammonia and Methionine Sulfoximine on myo-Inositol Transport in Cultured Astrocytes , 2004, Neurochemical Research.

[104]  D. Saunders,et al.  MR spectroscopy in stroke. , 2000, British medical bulletin.

[105]  M. Weiner,et al.  Proton MR spectroscopic imaging of the striatum in Parkinson's disease. , 1997, Magnetic resonance imaging.

[106]  K. Kogure,et al.  Molecular and biochemical events within the brain subjected to cerebral ischemia (targets for therapeutical intervention). , 1997, Clinical neuroscience.

[107]  P. Magistretti,et al.  Metabolic coupling during activation. A cellular view. , 1997, Advances in experimental medicine and biology.

[108]  M W Weiner,et al.  Mapping of lactate and N-acetyl-L-aspartate predicts infarction during acute focal ischemia: in vivo 1H magnetic resonance spectroscopy in rats. , 1996, Neurosurgery.

[109]  K. Arai,et al.  Therapeutic efficacy of a case of pyruvate dehydrogenase complex deficiency monitored by localized proton magnetic resonance spectroscopy. , 1996, Magnetic resonance imaging.

[110]  M. Fisher,et al.  Potentially effective therapies for acute ischemic stroke. , 1995, European neurology.

[111]  O. Petroff,et al.  Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. , 1995, Magnetic resonance imaging.

[112]  D. Leibfritz,et al.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.

[113]  J. Cedarbaum,et al.  Energy metabolism in disorders of the nervous system. , 1988, Revue neurologique.

[114]  G K Radda,et al.  NMR studies of tissue metabolism. , 1981, Annual review of biochemistry.